Delivery Order SPE2DB24D3015-SPE2DB25FGAAA
Award Date 7/2/25
Potential Completion Date 7/3/25
Potential Value $2.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Insulin Aspart 100 Unit/mL, a prescription medication used to treat diabetes. The contract has a ceiling value of $6,691.28 and a period of performance through March 7, 2025. It is a firm fixed-price contract, and there is no set-aside designation, indicating open competition....
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of INSULIN ASPART 100 UNIT/ML VL 10ML, a diabetes treatment medication. The award has a firm fixed price of $1,734.04 and a completion date of June 12, 2025. The contract is not set-aside and is an open competition award. Amerisourcebergen Drug Corp holds a significant...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Insulin Aspart 100 Unit/mL Pen 3mL, a critical diabetes medication. The contract has a total ceiling value of $1,098.84 and an ultimate completion date of December 21, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Insulin Aspart 100 Unit/mL Pen 3mL, a diabetes medication, with a ceiling value of $13,448.24. The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Insulin Aspart 100 Unit/mL Pen 3mL. The $6,125.48 firm fixed-price contract has an ultimate completion date of August 24, 2023. This order is a part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC enables the DLA to...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Insulin Aspart 100 Unit/mL Pen 3mL, a pharmaceutical product used for diabetes management. The contract has a ceiling value of $16,696.19 and an ultimate completion date of May 18, 2023. The contract was awarded on a Firm Fixed Price basis, without any set-aside designations, indicating open...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,564,743,151 units of Insulin Aspart 100 Unit/mL in 10 mL vials, with a ceiling value of $4,266.02. The contract has a firm fixed price pricing type and an ultimate completion date of May 30, 2024. The contract is not designated as a set-aside....
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Insulin Aspart 100 Unit/mL in 10 mL vials, with a ceiling value of $2,189.41 and a period of performance ending on May 19, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Insulin Aspart 100 Unit/mL Vial 10mL, a critical pharmaceutical product, to support military healthcare needs. The contract has a ceiling value of $3,417.48 and a period of performance through January 24, 2024. The contract is a firm-fixed-price delivery order, and there is no set-aside designation, indicating open...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,847.21, is for the delivery of insulin aspart 100 unit/mL pen 3mL. The contract has a completion date of June 27, 2025 and is a firm fixed-price delivery order. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...